BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7809953)

  • 21. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report.
    Gillin JC; Pulvirenti L; Withers N; Golshan S; Koob G
    Biol Psychiatry; 1994 Jun; 35(11):843-9. PubMed ID: 8054406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients.
    Kranzler HR; Bauer LO
    Br J Addict; 1992 Nov; 87(11):1537-48. PubMed ID: 1458033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
    Izzo E; Orsini C; Koob GF; Pulvirenti L
    Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels.
    Gorelick DA; Wilkins JN
    Drug Alcohol Depend; 2006 Feb; 81(2):189-95. PubMed ID: 16051446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine agonists for cocaine dependence.
    Soares BG; Lima MS; Reisser AA; Farrell M
    Cochrane Database Syst Rev; 2001; (4):CD003352. PubMed ID: 11687193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addictiveness of central stimulants.
    Dackis CA; Gold MS
    Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocaine reward and cocaine craving: the role of dopamine in perspective.
    Wise RA
    NIDA Res Monogr; 1994; 145():191-206. PubMed ID: 8742814
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The principles of agonist pharmacotherapy for psychostimulant dependence.
    Shearer J
    Drug Alcohol Rev; 2008 May; 27(3):301-8. PubMed ID: 18368612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
    Stracke H; Heinlein W; Horowski R; Schatz H
    Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin2C receptors and drug addiction: focus on cocaine.
    Devroye C; Filip M; Przegaliński E; McCreary AC; Spampinato U
    Exp Brain Res; 2013 Oct; 230(4):537-45. PubMed ID: 23748692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research.
    Ritz MC; Kuhar MJ
    Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
    Gál K; Gyertyán I
    Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic approaches to the treatment of cocaine dependence.
    Taylor WA; Gold MS
    West J Med; 1990 May; 152(5):573-7. PubMed ID: 1971975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine.
    Siciliano CA; Fordahl SC; Jones SR
    J Neurosci; 2016 Jul; 36(30):7807-16. PubMed ID: 27466327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine partial agonist reverses amphetamine withdrawal in rats.
    Orsini C; Koob GF; Pulvirenti L
    Neuropsychopharmacology; 2001 Nov; 25(5):789-92. PubMed ID: 11682262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
    Weissenborn R; Deroche V; Koob GF; Weiss F
    Psychopharmacology (Berl); 1996 Aug; 126(4):311-22. PubMed ID: 8878347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The neurobiology of psychostimulant addiction].
    Fernández-Espejo E
    Rev Neurol; 2006 Aug 1-15; 43(3):147-54. PubMed ID: 16871480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine abuse and dependence.
    Withers NW; Pulvirenti L; Koob GF; Gillin JC
    J Clin Psychopharmacol; 1995 Feb; 15(1):63-78. PubMed ID: 7714230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.